Results 141 to 150 of about 21,323,950 (308)
Spreading dynamics of β2 integrin-expressed human neutrophils onto ICAM-1-immobilized substrate [PDF]
, 2011 目的研究由表达于人中性粒细胞表面的β2整合素与胞间黏附分子-1(intercellular adhesion molecule-1,ICAM-1)裱衬表面相互作用介导人中性粒细胞铺展的动力学过程。方法以裱衬2%人血清白蛋白(human serumalbumin,HSA)和空白的底板为对照,分别考察裱衬了10、20和100μg/mL ICAM-1的底板上人中性粒细胞铺展比例随时间的变化规律。通过流式细胞仪检测人中性粒细胞β2整合素的表达量,以及采用抗体阻断β2整合素的CD11a或CD11b亚基 ...
龙勉, 展冬颖, 章燕
core
iMetaMed, EarlyView.This review systematically summarizes the central role of cysteine peptidases in modulating antigen‐presenting cell (APC) function and antitumor immune responses, highlighting their critical significance in overcoming tumor immune evasion. Current research has established that cysteine peptidase subtypes, including cathepsins B, S, L, and X, exert ...
Yimao Wu +7 more
wiley +1 more source
iMetaMed, EarlyView.Inflammatory bowel disease (IBD) is a chronic inflammatory disorder of the intestine associated with an imbalance in intestinal homeostasis. m6A‐modifying enzymes, consisting of m6A writers, erasers and readers, plays a pivotal role in the pathogenesis and progression of IBD by affecting four intestinal barriers, including the intestinal mechanical ...
Jiaxian Guo +4 more
wiley +1 more source
Zhongguo shiyan zhenduanxue, 2006 目的利用小片段干扰RNA（siRNA）在肝癌细胞内诱导RNA干扰（RNAi）,抑制细胞间粘附分子-1（ICAM-1）基因表达,在体外进行RNAi对肝癌治疗的实验研究。方法根据ICAM-1基因设计shRNA片断,构建pGenesil-1/ICAM-1表达载体,转入E.coli菌,并用Lipofectamine tm2000转染HepG2细胞,通过MTT方法检测细胞活性状态,应用免疫组织化学的方法检测肝癌细胞中ICAM-1基因蛋白质表达抑制情况。结果本实验已成功构建了针对ICAM-1基因的pGenesil ...
廖维甲 +5 more
doaj
Epigenetic Regulation in the Pathogenesis of Renal Inflammation: Insights and Therapeutic Potentials
iNew Medicine, EarlyView.ABSTRACT Renal inflammation is a common pathological process in various kidney diseases, often initiated by factors such as toxins, ischemia, or autoimmune reactions. This inflammatory response can result in structural damage and a rapid decline in renal function.
Yu‐Hang Dong +5 more
wiley +1 more source
iNew Medicine, EarlyView.ABSTRACT Insulin resistance is the biological phenomenon in which the human body's normal response to the metabolic hormone insulin is compromised. Insulin is a regulator of most of the essential metabolic steps in the body that control energy homoeostasis, so dysregulation leads to multiple diverse human diseases including, most prominently, Type 2 ...
Peter J. Little +12 more
wiley +1 more source
Metrnl: A Novel Therapeutic Target in Atherosclerosis
iNew Medicine, EarlyView.ABSTRACT Atherosclerosis is a chronic inflammatory vascular disease and the main pathological basis of cardiovascular and cerebrovascular events. Exploration of endogenous protective factors in the disease is beneficial for the establishment of new therapeutic strategies.
Pin Wang, Dao‐Xin Wang, Chao‐Yu Miao
wiley +1 more source
Interdisciplinary Medicine, EarlyView.The graphical abstract outlines a novel multifunctional ultrasound contrast agent for the diagnosis and treatment of ischemic diseases, along with innovative strategies to enhance its targeting efficiency. Abstract Ischemic diseases, such as myocardial infarction, stroke, and peripheral ischemia, are leading causes of death and disability worldwide ...
Yangyang Zhou +3 more
wiley +1 more source
Journal of the American Heart Association: Cardiovascular and Cerebrovascular DiseaseBackground Although VCAM‐1 (vascular cell adhesion molecule‐1) and ICAM‐1 (intercellular adhesion molecule‐1) have been associated with incident heart failure with preserved ejection fraction (HFpEF) and atrial fibrillation (AF), the associations of VCAM‐
Daniel T. Mathew +7 more
doaj +1 more source